BFMO (biogenic Fe-Mn oxides)
CAS No. 69010-90-8
BFMO (biogenic Fe-Mn oxides)( N,N'-Difurfuryloxamide )
Catalog No. M27531 CAS No. 69010-90-8
BFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 206 | In Stock |
|
| 10MG | 345 | In Stock |
|
| 25MG | 579 | In Stock |
|
| 50MG | 824 | In Stock |
|
| 100MG | 1125 | In Stock |
|
| 500MG | 2232 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBFMO (biogenic Fe-Mn oxides)
-
NoteResearch use only, not for human use.
-
Brief DescriptionBFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously.
-
DescriptionBFMO (biogenic Fe-Mn oxides, defined as a mixture of biogenic Mn oxide (BMO) and Fe oxide) could eliminate or decrease Fe(II), Mn(II), and As(III&V) species simultaneously. Moreover, BFMO can be used for As removal from water containing high concentrations of Fe(II) and Mn(II).
-
In Vitro——
-
In Vivo——
-
SynonymsN,N'-Difurfuryloxamide
-
PathwayOthers
-
TargetOther Targets
-
Recptorβ2-adrenergic receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number69010-90-8
-
Formula Weight248.23
-
Molecular FormulaC12H12N2O4
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(C(NCc1ccco1)=O)NCc1ccco1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Dimri M, et al. Todralazine protects zebrafish from lethal effects of ionizing radiation: role of hematopoietic cell expansion. Zebrafish. 2015 Feb;12(1):33-47.
molnova catalog
related products
-
Atanine
Atanine is a useful organic compound for research related to life sciences.
-
Parvisoflavanone
Parvisoflavanone may have α-Glucosidase inhibitory activity.
-
Bruceoside A
Bruceoside A could be transformed into the potent anticancer component brusatol in vivo, rather than its direct deglycosylated metabolite bruceosin.
Cart
sales@molnova.com